11.2 Central Fill, Centralized Processing & Shared Pharmacy Services

From Central Fill to "Shared Pharmacy Services"

New York's path to permitting multi-pharmacy prescription processing has been unusually winding, and the history itself is testable because it explains why NY uses the term "shared pharmacy services" rather than "central fill."

Why NY Abandoned the 2023 Central Fill Rule

On June 28, 2023, NYSED published a proposed regulation that would have created a distinct central fill pharmacy registration class — a facility not open to the public that would only prepare and fill prescriptions forwarded from an "originating" pharmacy, with a bar on direct-to-patient shipping and a requirement that the originating pharmacy obtain the patient's written consent before any prescription went to central fill. NYSED never finalized that rule. On September 12, 2023, the department announced it was abandoning the regulatory approach and would instead pursue a statutory fix — meaning the underlying authority needed to come from the Legislature, not just a Commissioner's regulation.

Education Law §6809: What It Authorizes

The Legislature answered on November 22, 2024, when the Governor signed a bill adding Education Law §6809 ("Shared pharmacy services") to Article 137. The statute took effect May 22, 2026 — eighteen months after enactment. Under §6809, a "dispensing" pharmacy may forward some or all of a prescription's processing (verification, drug utilization review, filling) to a "cooperating" pharmacy, which returns it for pickup or delivery to the patient. Participating pharmacies must be registered under Education Law §6805, §6808, or §6808-b, and must either share common ownership or operate under a written contract spelling out each pharmacy's responsibilities, data-sharing terms, and compliance obligations.

Patient Protections

§6809 builds in several patient-facing safeguards:

Labeling & Recordkeeping

Every pharmacy that touches a shared-services prescription — dispensing and cooperating alike — must have its name and registration number on the finished label. Participating pharmacies must also maintain a tracking system documenting each processing step and every pharmacist, technician, and facility involved, so the Board can reconstruct exactly who did what to a given prescription.

Licensure — The NYBOP Individual-Pharmacist Wrinkle

The most consequential open question after the statute passed was whether an individual pharmacist working for an out-of-state cooperating pharmacy — including one working remotely and never physically present in New York — needs a personal New York pharmacist registration to touch a New York patient's prescription under a shared-services arrangement. In March 2026, NYBOP confirmed a strict reading: both the pharmacy and each individual pharmacist participating in shared services for New York patients must be separately registered/licensed in New York, grounding the position in Education Law §6802(30) (the definitions provision) and §6809 itself. This is a stricter posture than many other states take toward shared-services and mail-order arrangements, where typically only the pharmacy — not each remote pharmacist — needs in-state registration. Multistate chains must audit which of their remote-processing pharmacists actually hold NY licensure before routing New York prescriptions to them.

Implementing Regulations

NYSED published proposed regulations on September 24, 2025 to conform 8 NYCRR Part 63 to the new statute, with a 60-day public comment period running through November 23, 2025. Those regulations were expected to be finalized before the May 22, 2026 effective date. MPJE candidates should treat §6809's statutory text — signage, one-time consent with opt-out, dual labeling, tracking, and the NYBOP individual-licensure position — as the settled core, while recognizing that implementing-regulation details may continue to be refined as the rule is finalized.

What Counts as "Processing"

§6809 is deliberately broad about which functions can move to a cooperating pharmacy — the statute speaks in terms of "processing and/or fulfillment" rather than listing discrete clinical tasks. In practice this covers steps such as prescription data entry, prospective drug utilization review, therapeutic verification, and the physical filling of the prescription. It does not relieve either pharmacy of its independent legal duties: the dispensing pharmacy remains responsible for the patient relationship and final release of the prescription, while the cooperating pharmacy is responsible for the steps it actually performs. A pharmacist who verifies a prescription for a shared-services arrangement is exercising professional judgment on that prescription just as if the patient had walked into their own pharmacy, and ordinary standard-of-care and recordkeeping duties travel with the task.

Out-of-State Pharmacies

Any nonresident pharmacy that enters a shared-services arrangement with a New York pharmacy, or that ends up processing or filling New York patients' prescriptions through that arrangement, must separately hold nonresident pharmacy registration in New York (see 11.4) — participation in shared services does not substitute for that registration.

Traps

• NY never adopted a separate "central fill" registration class — the 2023 draft was withdrawn; the operative statute is the broader shared pharmacy services law (§6809).
• Consent is one-time, not per-prescription, but it must cover current and future prescriptions and remains revocable at any time.
• Do not assume only the pharmacy needs NY registration — NYBOP's 2026 position also requires the individual remote pharmacist to be NY-registered.
• The label must show every participating pharmacy's name and registration number, not just the dispensing pharmacy's.